The settlement removes future financial uncertainty and potential cash outflows. With a 40% discount achieved and the counterparty in liquidation, this appears to be a favorable resolution. Monitor for any impact on the company's cash position and whether this affects future R&D or commercialization timelines for the Memogain technology.
Price Chart
Executive Summary
Alpha Cognition Inc. settled future royalty and milestone obligations to Galantos Pharma for EUR 5.21 million, extinguishing all remaining payments under a 2013 asset purchase agreement. The settlement represents a 40% discount to the estimated value of future obligations.
Key Financial Metrics
Key Facts
- Alpha Cognition settled future royalty and milestone obligations to Galantos Pharma for EUR 5.21 million (approximately $5.7 million at current exchange rates)
- The payment extinguishes all remaining contingent obligations under the 2013 Memogain Asset Purchase Agreement
- The settlement represents a 40% discount to the estimated market value of the remaining obligations
- Galantos is in liquidation, creating urgency to settle claims
- No further payments will be due under the original agreement
Financial Impact
EUR 5.21 million one-time payment, representing a 40% discount to estimated future obligations
Risk Factors
- One-time cash outflow of $5.7 million could impact liquidity
- Potential loss of rights or flexibility related to the Memogain technology
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-043517 |
| Document: ea0285983-8k_alpha.htm | 0001213900-26-043517 |
| Document: 0001213900-26-043517-index-headers.html | 0001213900-26-043517 |
| Document: 0001213900-26-043517-index.html | 0001213900-26-043517 |
| Document: 0001213900-26-043517.txt | 0001213900-26-043517 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 28, 2026 28d ago | Insider Buy | $8.71 $8.98 | ▲ +3.10% | ▲ +1.15% | $8.30 (−4.71%) |
Sep 23, 2026 4w ago | SC 13G | $8.57 $8.70 | ▲ +1.52% | ▲ +1.93% | $8.30 (−3.15%) |
Sep 16, 2026 5w ago | Insider Buy | $8.85 $8.57 | ▼ −3.16% | ▼ −3.76% | $8.30 (−6.21%) |
Aug 24, 2026 9w ago | Insider Buy | $9.75 $9.27 | ▼ −4.92% | ▼ −5.39% | $8.30 (−14.87%) |
May 19, 2026 22w ago | Insider Cluster | $5.89 $5.94 | ▲ +0.85% | ▼ −0.95% | $8.30 (+40.92%) |
Apr 20, 2026 27w ago | 8-K | $6.88 $6.20 | ▼ −9.88% | ▼ −10.97% | $8.30 (+20.64%) |
Apr 14, 2026 27w ago | 8-K | $6.75 $6.99 | ▲ +3.56% | ▲ +1.92% | $8.30 (+22.96%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers